1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Delayed London Stock Exchange  -  05/24 11:35:14 am EDT
10598.00 GBX   -0.02%
08:45aIndian vaccine giant Serum plans African plant in global expansion
RE
08:43aDanske Bank Initiates Coverage on AstraZeneca With Buy Rating
MT
05:18aVaxzevria approved in the EU as third dose booster against COVID-19
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca Reportedly Weighs Listing of Newly-Created Vaccines Unit

12/03/2021 | 03:08pm EDT


© MT Newswires 2021
All news about ASTRAZENECA PLC
08:45aIndian vaccine giant Serum plans African plant in global expansion
RE
08:43aDanske Bank Initiates Coverage on AstraZeneca With Buy Rating
MT
05:18aVaxzevria approved in the EU as third dose booster against COVID-19
AQ
05:18aAstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022
AQ
03:58aAstraZeneca COVID-19 vaccine approved in the EU as third dose booster against COVID-19
AQ
02:12aTrial Scheduled For April 2024 In BMS Patent Case Against AstraZeneca Regarding Anti-PD..
AQ
05/23EU Drug Regulator Approves AstraZeneca's COVID-19 Vaccine as Third-Dose Booster
MT
05/23U.S. Task Force to consider routine kidney disease screening as new drugs available
RE
05/23What you need to know about the coronavirus right now
RE
05/23AstraZeneca's COVID-19 Vaccine Gets EU Approval as Third Booster Dose
MT
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2022 43 711 M - -
Net income 2022 5 290 M - -
Net Debt 2022 23 006 M - -
P/E ratio 2022 39,1x
Yield 2022 2,21%
Capitalization 207 B 206 B -
EV / Sales 2022 5,25x
EV / Sales 2023 4,82x
Nbr of Employees 83 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 133,28 $
Average target price 143,91 $
Spread / Average Target 7,97%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC22.15%206 509
JOHNSON & JOHNSON4.89%472 179
PFIZER, INC.-10.45%296 704
ROCHE HOLDING AG-14.40%273 052
ELI LILLY AND COMPANY9.55%272 388
ABBVIE INC.9.33%261 585